• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Cimidona
    / Rafa


    Active Ingredient
    Cimicifugae Dry Extract (Black cohosh) 6.5 mg

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Tablets

    30 X 6.5 mg

    not in the basket chart 33008 9907

    Tablets

    90 X 6.5 mg

    not in the basket chart

    Related information


    Dosage

    1 tablet to be taken once daily, unchewed, with some fluid, preferably always at the same time of the day (in the morning or in the evening). The intake of the tablets does not depend on meals.
    The effect does not set in immediately. Intake of the formulation is recommended for a period of at least 6 weeks.
    It is recommended to take the drug over several months; however, it should not be applied for more than 6 months without medical advice.


    Indications

    For the alleviation of complaints during menopause (hot flashes, excessive perspiration, sleep disorders, nervousness and depressive moods).


    Contra-Indications

    Must not be taken in cases of existing hypersensitivity to one of its ingredients or to any plants of the Ranunculaceae (butter cup) family.


    Special Precautions

    The intake of the formulation is not advised in cases of pre-existing liver damage. This preparation has an effect on physical and psychological complaints during the menopause. Since there is no clinical data so far with regard to a positive effect on bones, this preparation can therefore not be used for the prevention of osteoporosis.
    Unusual fatigue, weakness or loss of appetite and unintended weight loss, yellow colouring of the conjunctiva or the skin, dark urine, or discolouration of stool can be an indication of liver damage. If such symptoms occur, the drug must be discontinued and a physician must be consulted.
    A physician should be consulted in the event of a sensation of tension or swelling in the breasts or if irregular bleeding, spotting, or recurrence of menstrual bleeding occurs.
    See prescribing information for full details.


    Side Effects

    Slight gastric complaints, nausea, severe liver damage, spotting and irregular bleeding as well as recurrence of menstrual bleeding can be observed in individual cases.
    See prescribing information for full details.


    Drug interactions

    None known.


    Pregnancy and Lactation

    The use of preparations containing Cimicifugae racemosae rhizoma is indicated for menopausal women. Administration during pregnancy and lactation is not intended.


    Overdose

    No cases of overdose were reported.


    Manufacturer
    Max Zeller Sohne
    CLOSE